Summary
This event is an introductory course that will give an overview of how to negotiate and draft effective license agreements, whether you are the licensor or licensee. Experts in licensing will discuss different kinds of licensing agreements, and the business and legal issues related to them.
Related Content
- AlertNovember 21, 2024
Second Circuit Sees Eye to Eye With Warby Parker in Trademark Google Ads Dispute
- InsightNovember 1, 2024
Four Steps to Maximize the Value of AI Innovation in Medtech
- InsightSeptember 9, 2024
Are AI Inventions Harder to Patent?
- InsightAugust 14, 2024
FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision
- AlertAugust 2, 2024
USPTO Issues Further Guidance on AI-Related Patent Eligibility
- InsightJuly 25, 2024
The Rapid Rise of AI, in Five Charts
- AlertMay 22, 2024
The Appeals Review Panel’s In Re Xencor Decision: The USPTO Provides Its Position on Written Description and Means-Plus-Function Claims
- AlertMarch 12, 2024
USPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences
- Awards and RankingsFebruary 4, 2025
Goodwin Named a Top Firm in World Trademark Review for the Tenth Consecutive Year
- Press ReleaseJanuary 13, 2025
Goodwin's Top Ranked Life Sciences Practice Enhances Intellectual Property Expertise with the Addition of Carl Morales in New York
- Press ReleaseJanuary 13, 2025
Leading PTAB Expert Dr. Theodoros Konstantakopoulos Joins Goodwin’s Intellectual Property Litigation Practice in New York
- In the PressJanuary 13, 2025
Goodwin Adds NY IP Attys (Law360)
- In the PressJanuary 13, 2025
Goodwin, Leaning Into IP Work, Hires 2 Lateral Partners in NY (The American Lawyer)
- Press ReleaseDecember 19, 2024
Novo Holdings Completes $16.5 Billion Acquisition of Catalent
- Press ReleaseDecember 6, 2024
Goodwin Represents the Initial Purchasers on Galaxy Digital’s $402.5 Million 2.500% Exchangeable Senior Notes Offering
- Press ReleaseDecember 6, 2024
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.